Search Results - "Blome, C."

Percentage of scalp‐hair loss as a primary endpoint in alopecia areata trials by Blome, C.

“…Linked Article: Wyrwich et al. Br J Dermatol 2020; 183:702–709…”
Get full text

Measuring what's important to adolescents with psoriasis by Blome, C.

“…Linked Article: Randa et al. Br J Dermatol 2020; 183:96–104…”
Get full text

Classifying the severity of bullous pemphigoid disease by Blome, C., Klein, T.M.

“…Linked Article: Masmoudi et al. Br J Dermatol 2021; 184:1106–1112…”
Get full text

Gender and age significantly determine patient needs and treatment goals in psoriasis – a lesson for practice by Maul, J.‐T., Navarini, A.A., Sommer, R., Anzengruber, F., Sorbe, C., Mrowietz, U., Drach, M., Blome, C., Boehncke, W.‐H., Thaci, D., Reich, K., Kiedrowski, R., Körber, A., Yawalkar, N., Mainetti, C., Laffitte, E., Streit, M., Rustenbach, S., Conrad, C., Borradori, L., Gilliet, M., Cozzio, A., Itin, P., Häusermann, P., French, L.E., Radtke, M.A., Augustin, M.

“…Background Though patient needs are key drivers of treatment decisions, they are rarely systematically investigated in routine care. Objective This study aimed…”
Get full text

Pruritus assessment in clinical trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials by Ständer, Sonja, Augustin, Matthias, Reich, Adam, Blome, Christine, Ebata, Toshiya, Phan, Ngoc Quan, Szepietowski, Jacek C

“…Chronic pruritus is a common symptom and there is an urgent need to test new anti-pruritic substances in high-quality clinical trials. However, no widely…”
Get full text

Nail psoriasis in Germany: epidemiology and burden of disease by Augustin, M., Reich, K., Blome, C., Schäfer, I., Laass, A., Radtke, M.A.

“…Summary Background  Although nail psoriasis affects a marked proportion of patients with psoriasis and causes significant psychological stress, only few…”
Get full text

Validation of a short‐form of the Freiburg Life Quality Assessment for lymphoedema (FLQA‐LS) instrument by Augustin, M., Conde Montero, E., Hagenström, K., Herberger, K., Blome, C.

“…Summary Background Chronic lymphoedema (CLE) is a burdensome disease of multiple causes leading to significant reductions in health‐related quality of life…”
Get full text

Characterizing treatment‐related patient needs in atopic eczema: insights for personalized goal orientation by Augustin, M., Langenbruch, A., Blome, C., Gutknecht, M., Werfel, T., Ständer, S., Steinke, S., Kirsten, N., Silva, N., Sommer, R.

“…Background Atopic eczema (AE) is a common and burdensome chronic skin disease. Clinical guidelines suggest an evidence‐based, personalized and stepwise…”
Get full text

Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730 by Ständer, S, Schäfer, I, Phan, N Q, Blome, C, Herberger, K, Heigel, H, Augustin, M

“…Pruritus is a frequent symptom in many diseases; its prevalence in German adults is unknown. Our purpose was to assess the prevalence, severity and health care…”
Get more information

Cross‐European validation of the ItchyQoL in pruritic dermatoses by Zeidler, C., Steinke, S., Riepe, C., Bruland, P., Soto‐Rey, I., Storck, M., Garcovich, S., Blome, C., Bobko, S., Legat, F.J., Potekaev, N., Lvov, A., Misery, L., Weger, W., Reich, A., Şavk, E., Streit, M., Serra‐Baldrich, E., Szepietowski, J.C., Yosipovitch, G., Chen, S.C., Dugas, M., Ständer, S.

“…Background Chronic pruritus (CP) is a frequently occurring symptom in inflammatory dermatoses, causing a high burden and limitations to health‐related quality…”
Get full text

Cost‐of‐illness of patients with lymphoedema by Gutknecht, M., Herberger, K., Klose, K., Purwins, S., Dietz, D., Blome, C., Augustin, M.

“…Background Chronic lymphoedema is characterized by a continuous need for medical treatment, many comorbidities and impaired quality of life. In Germany, about…”
Get full text

Novel TRPM8 agonist cooling compound against chronic itch: results from a randomized, double‐blind, controlled, pilot study in dry skin by Ständer, S., Augustin, M., Roggenkamp, D., Blome, C., Heitkemper, T., Worthmann, A.C., Neufang, G.

“…Background Patients suffering from chronic pruritus (CP) due to dry skin with are often applying emollients containing menthol. However, topical menthol may be…”
Get full text

Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey by Radtke, MA, Reich, K, Blome, C, Rustenbach, S, Augustin, M

“…Psoriatic arthritis (PsA) is a chronic, systemic, inflammatory disorder characterized by the association of arthritis with psoriasis. Patients with PsA may…”
Get full text

Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID‐19 pandemic by Chernyshov, P.V., Tomas‐Aragones, L., Augustin, M., Svensson, A., Bewley, A., Poot, F., Szepietowski, J.C., Marron, S.E., Manolache, L., Pustisek, N., Suru, A., Salavastru, C.M., Blome, C., Salek, M.S., Abeni, D., Sampogna, F., Dalgard, F., Linder, D., Evers, A.W.M., Finlay, A.Y.

“…The pandemic of COVID‐19 is a global challenge for health care, and dermatologists are not standing apart from trying to meet this challenge. The European…”
Get full text

Chronic pruritus: evaluation of patient needs and treatment goals with a special regard to differences according to pruritus classification and sex by Steinke, S., Bruland, P., Blome, C., Osada, N., Dugas, M., Fritz, F., Augustin, M., Ständer, S.

“…Summary Background Chronic pruritus (CP) is present in approximately one‐third of all dermatological patients. Diagnostics and treatment are challenging and…”
Get full text

Pruritus Intensity Scales across Europe: a prospective validation study by Storck, M., Sandmann, S., Bruland, P., Pereira, M.P., Steinke, S., Riepe, C., Soto‐Rey, I., Garcovich, S., Augustin, M., Blome, C., Bobko, S., Legat, F.J., Potekaev, N., Lvov, A., Misery, L., Weger, W., Reich, A., Şavk, E., Streit, M., Serra‐Baldrich, E., Szepietowski, J.C., Dugas, M., Ständer, S., Zeidler, C.

“…Background Chronic pruritus (CP) is a subjective symptom, and it is necessary to assess its intensity with validated patient‐reported outcome tools in order to…”
Get full text

Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes by Chernyshov, P.V., Tomas‐Aragones, L., Finlay, A.Y., Manolache, L., Marron, S.E., Sampogna, F., Spillekom‐van Koulil, S., Pustisek, N., Suru, A., Evers, A.W.M., Salavastru, C., Svensson, A., Abeni, D., Blome, C., Poot, F., Jemec, G.B.E., Linder, D., Augustin, M., Bewley, A., Salek, S.S., Szepietowski, J.C.

“…New treatment options may lead to an increased interest in using reliable and sensitive instruments to assess health‐related quality of life in people with…”
Get full text

Quality of life measurement in teledermatology. Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Teledermatology by Chernyshov, P. V., Finlay, A. Y., Tomas‐Aragones, L., Tognetti, L., Moscarella, E., Pasquali, P., Manolache, L., Pustisek, N., Svensson, A., Marron, S. E., Bewley, A., Salavastru, C., Suru, A., Koumaki, D., Linder, D., Abeni, D., Augustin, M., Blome, C., Salek, S. S., Evers, A. W. M., Poot, F., Sampogna, F., Szepietowski, J. С.

“…Many events, including the COVID‐19 pandemic, have accelerated the implementation of teledermatology pathways within dermatology departments and across…”
Get full text

Quality of life evaluation in lymphoedema by Augustin, M., Conde Montero, E., Hagenström, K., Herberger, K., Blome, C.

“…Summary The lymphatic system is a network of small vessels draining clear fluid (lymph) from all bodily tissues. Many different disorders, including birth…”
Get full text

Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial) by Kähler, Katharina C., Hüning, S., Nashan, D., Meiss, F., Rafei-Shamsabadi, D. A., Rissmann, H., Colapietro, C., Livingstone, E., Maul, L. V., Heppt, M., Hassel, J. C., Gutzmer, R., Loquai, C., Heinzerling, L., Sachse, M. M., Bohne, A. S., Moysig, L., Peters, W., Rusch, J., Blome, C.

“…Purpose Adjuvant treatment with immune checkpoint inhibitors like PD1-antibodies (ICI) ± CTLA4-antibodies (cICI) or targeted therapy with BRAF/MEK inhibitors…”
Get full text